183 related articles for article (PubMed ID: 20861217)
1. Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity.
Bardowell SA; Stec DE; Parker RS
J Nutr; 2010 Nov; 140(11):1901-6. PubMed ID: 20861217
[TBL] [Abstract][Full Text] [Related]
2. Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega-hydroxylase.
Sontag TJ; Parker RS
J Lipid Res; 2007 May; 48(5):1090-8. PubMed ID: 17284776
[TBL] [Abstract][Full Text] [Related]
3. Disruption of mouse cytochrome p450 4f14 (Cyp4f14 gene) causes severe perturbations in vitamin E metabolism.
Bardowell SA; Duan F; Manor D; Swanson JE; Parker RS
J Biol Chem; 2012 Jul; 287(31):26077-86. PubMed ID: 22665481
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status.
Sontag TJ; Parker RS
J Biol Chem; 2002 Jul; 277(28):25290-6. PubMed ID: 11997390
[TBL] [Abstract][Full Text] [Related]
5. Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism.
Parker RS; Sontag TJ; Swanson JE; McCormick CC
Ann N Y Acad Sci; 2004 Dec; 1031():13-21. PubMed ID: 15753130
[TBL] [Abstract][Full Text] [Related]
6. Disruption of P450-mediated vitamin E hydroxylase activities alters vitamin E status in tocopherol supplemented mice and reveals extra-hepatic vitamin E metabolism.
Bardowell SA; Ding X; Parker RS
J Lipid Res; 2012 Dec; 53(12):2667-76. PubMed ID: 22969154
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphism in human CYP4F2 decreases 20-HETE production.
Stec DE; Roman RJ; Flasch A; Rieder MJ
Physiol Genomics; 2007 Jun; 30(1):74-81. PubMed ID: 17341693
[TBL] [Abstract][Full Text] [Related]
8. Long-chain carboxychromanols are the major metabolites of tocopherols and tocotrienols in A549 lung epithelial cells but not HepG2 cells.
You CS; Sontag TJ; Swanson JE; Parker RS
J Nutr; 2005 Feb; 135(2):227-32. PubMed ID: 15671218
[TBL] [Abstract][Full Text] [Related]
9. ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol.
Farley SM; Leonard SW; Taylor AW; Birringer M; Edson KZ; Rettie AE; Traber MG
Mol Nutr Food Res; 2013 Oct; 57(10):1785-93. PubMed ID: 23650179
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials.
Athinarayanan S; Wei R; Zhang M; Bai S; Traber MG; Yates K; Cummings OW; Molleston J; Liu W; Chalasani N
PLoS One; 2014; 9(4):e95366. PubMed ID: 24759732
[TBL] [Abstract][Full Text] [Related]
11. ω-Hydroxylation of α-tocopheryl quinone reveals a dual function for cytochrome P450-4F2 in vitamin E metabolism.
Taylor L; Krueger N; Malysheva O; Atkinson J; Parker RS
Bioorg Med Chem; 2018 Nov; 26(20):5555-5565. PubMed ID: 30316641
[TBL] [Abstract][Full Text] [Related]
12. Insights into the binding mechanism between α-TOH and CYP4F2: A homology modeling, molecular docking, and molecular dynamics simulation study.
Liang L; Zheng Q
J Cell Biochem; 2023 Apr; 124(4):573-585. PubMed ID: 36924012
[TBL] [Abstract][Full Text] [Related]
13. Functional Characterization of 29 Cytochrome P450 4F2 Variants Identified in a Population of 8380 Japanese Subjects and Assessment of Arachidonic Acid
Sato Y; Hishinuma E; Yamazaki S; Ueda A; Kumondai M; Saito S; Tadaka S; Kinoshita K; Nakayoshi T; Oda A; Maekawa M; Mano N; Hirasawa N; Hiratsuka M
Drug Metab Dispos; 2023 Dec; 51(12):1561-1568. PubMed ID: 37775333
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11.
Edson KZ; Prasad B; Unadkat JD; Suhara Y; Okano T; Guengerich FP; Rettie AE
Biochemistry; 2013 Nov; 52(46):8276-85. PubMed ID: 24138531
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E and drug metabolism.
Brigelius-Flohé R
Biochem Biophys Res Commun; 2003 Jun; 305(3):737-40. PubMed ID: 12763054
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE).
Kim WY; Lee SJ; Min J; Oh KS; Kim DH; Kim HS; Shin JG
Prostaglandins Leukot Essent Fatty Acids; 2018 Apr; 131():6-13. PubMed ID: 29628049
[TBL] [Abstract][Full Text] [Related]
17. CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.
McDonald MG; Rieder MJ; Nakano M; Hsia CK; Rettie AE
Mol Pharmacol; 2009 Jun; 75(6):1337-46. PubMed ID: 19297519
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of oxidative metabolism of tocopherols with omega-N-heterocyclic derivatives of vitamin E.
Ohnmacht S; Nava P; West R; Parker R; Atkinson J
Bioorg Med Chem; 2008 Aug; 16(16):7631-8. PubMed ID: 18656365
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
Powell PK; Wolf I; Jin R; Lasker JM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
[TBL] [Abstract][Full Text] [Related]
20. Computational analysis of missense variant CYP4F2*3 (V433M) in association with human CYP4F2 dysfunction: a functional and structural impact.
Farajzadeh-Dehkordi M; Mafakher L; Samiee-Rad F; Rahmani B
BMC Mol Cell Biol; 2023 May; 24(1):17. PubMed ID: 37161313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
